atracurium besylate injection, solution
auromedics pharma llc - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate 50 mg in 5 ml - atracurium besylate injection, usp is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.
cisatracurium besylate injection solution
accord healthcare inc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
atracurium kalceks 10 mgml
a.l. medi-market ltd. - atracurium besylate - solution for injection / infusion - atracurium besylate 10 mg / 1 ml - atracurium - atracurium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation.
cisatracurium besylate injection solution
mylan pharmaceuticals ulc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
cisatracurium besylate injection solution
pfizer canada ulc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
atracurium besylate- atracurium besylate injection, solution
mylan institutional llc - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate injection, usp is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it.
cisatracurium accord cisatracurium (as besilate) 5 mg /2.5 ml solution for injection vial
accord healthcare pty ltd - cisatracurium besilate, quantity: 6.7 mg (equivalent: cisatracurium, qty 5 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit
cisatracurium accord cisatracurium (as besilate) 50 mg / 25 ml solution for injection vial
accord healthcare pty ltd - cisatracurium besilate, quantity: 67 mg (equivalent: cisatracurium, qty 50 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit
cisatracurium-aft
aft pharmaceuticals ltd - cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v - solution for injection - 2 mg/ml - active: cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
cisatracurium juno cisatracurium besilate 150mg/30ml solution for injection vial
juno pharmaceuticals pty ltd - cisatracurium besilate, quantity: 211.05 mg (equivalent: cisatracurium, qty 157.5 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.